Ikarian Capital, LLC Annexon, Inc. Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $4.44 Million - $6.96 Million	-1,025,000 Reduced 72.95%	380,000 $1.86 Million
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $5.02 Million - $9.72 Million	-1,245,000 Reduced 46.98%	1,405,000 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $4.32 Million - $12.3 Million	2,650,000 New	2,650,000 $12 Million

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $249M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.